IGF – 1LR3 1mg

Comprehensive Guide to IGF-1 LR3 1mg (Long-R3 Insulin-like Growth Factor-I): Analogue Structure, Mitogenic Research Standards, and Analytical Purity

Welcome to Suzhou Lanhai Peptide, your trusted global source for advanced synthetic peptides, amino acid derivatives, and specialized laboratory storage solutions. In modern cellular biology research, mitogenic signaling studies, and advanced pharmaceutical formulation research, investigating modified growth factor analogues requires absolute precision, verifiable purity, and strict compliance with research standards. When exploring cell proliferation kinetics, insulin-like growth factor receptor (IGF-1R) binding, and extended in vitro half-life mechanics, utilizing high-purity IGF-1 LR3 1mg (Long-R3 Insulin-like Growth Factor-I) is vital for achieving reproducible scientific outcomes.

This comprehensive guide explores the structural modifications, biochemical properties, analytical verification standards, and proper laboratory storage protocols for IGF-1 LR3 1mg. By examining real-world industry benchmarks and analytical chemistry standards, we outline why optimized sourcing and handling are fundamental to advanced molecular and cell culture research.

1. Understanding IGF-1 LR3: Structure, Mechanism, and Research Scope

IGF-1 LR3 is a long-acting, synthetic analogue of human insulin-like growth factor-I (IGF-I). It consists of the complete 70-amino acid sequence of human IGF-I with two distinct structural modifications: the substitution of an arginine for the glutamic acid at position 3 (preventing major binding to IGF-binding proteins), and an 13-amino acid extension peptide at the N-terminus.

The Mechanism of Action in Biomedical Research

In contemporary biochemical and pharmacological investigations, IGF-1 LR3 is examined for several key cellular pathways:

• Reduced IGF-Binding Protein (IGFBP) Affinity: Because the Glu3-to-Arg mutation substantially lowers its binding affinity for endogenous IGF-binding proteins (IGFBPs), IGF-1 LR3 remains largely unbound and freely active in cell culture media, vastly increasing its biological potency compared to native IGF-I.

• IGF-1 Receptor (IGF-1R) Tyrosine Kinase Activation: It binds with high specificity to the transmembrane receptor tyrosine kinase IGF-1R, initiating downstream intracellular signaling cascades including PI3K/Akt and MAPK/ERK pathways.

• Cell Proliferation and Metabolic Studies: In vitro laboratory investigations utilize IGF-1 LR3 to stimulate cellular mitosis, support serum-free or low-serum cell culture growth lines, and study protein synthesis and hypertrophy kinetics.

2. Analytical Verification and High-Purity Synthesis Standards

For institutional buyers, academic researchers, and biotechnology procurement managers, batch verification is paramount. Recombinant and synthetic long-chain growth factor proteins require rigorous expression systems or solid-phase synthesis followed by refolding, high-performance liquid chromatography (HPLC), and mass spectrometry to ensure exact molecular weight and structural conformation.

High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS)

Every batch of IGF-1 LR3 1mg distributed by Suzhou Lanhai Peptide undergoes rigorous verification via HPLC and MS to guarantee purity levels exceeding 98%, ensuring minimal degradation products, truncated sequences, or incorrect folding anomalies.

Technical Specification Comparison

3. Laboratory Handling, Reconstitution, and Storage Protocols

Large recombinant proteins and modified growth factors like IGF-1 LR3 are supplied as stabilized, vacuum-freeze-dried (lyophilized) powders to maximize shelf-life stability. Proper laboratory handling is essential to preserve tertiary structure and biological activity upon reconstitution.

Reconstitution Best Practices

• Solvent Selection: Reconstitute lyophilized IGF-1 LR3 1mg using sterile 10 mM hydrochloric acid (HCl) or acetic acid solution, followed by dilution in neutral buffer systems as required by experimental protocols, operating in a clean laminar flow hood.

• Avoiding Shear Stress: Introduce solvents gently down the inside wall of the vial rather than forcefully vortexing or shaking, which can induce mechanical denaturation of the protein structure.

Cold-Chain Storage Guidelines

• Dry Powder Storage: Store sealed vials of lyophilized IGF-1 LR3 at $-20^\circ C$ desiccated away from light and moisture.

• Reconstituted Storage: Once reconstituted, protein solutions should be aliquoted, stored between $-20^\circ C$ and $-80^\circ C$ if possible to avoid repeated freeze-thaw cycles, or kept short-term at $2^\circ C$ to $8^\circ C$.

4. Mandatory Research Disclaimer and Compliance

• For Laboratory and Research Use Only: All peptide and protein products offered by Suzhou Lanhai Peptide, including IGF-1 LR3 1mg, are strictly intended for in vitro laboratory research, cell culture studies, and analytical testing. They are not approved for human consumption, clinical trials on humans, veterinary use, or therapeutic self-administration.

5. Frequently Asked Questions (FAQs)

1. What makes IGF-1 LR3 different from native human IGF-1?

IGF-1 LR3 features an N-terminal extension and a glutamic-to-arginine substitution at position 3, which together prevent binding to IGF-binding proteins and significantly extend its active half-life in in vitro assays.

2. What purity level does Suzhou Lanhai Peptide guarantee for IGF-1 LR3 1mg?

Every batch of IGF-1 LR3 1mg is backed by analytical documentation confirming HPLC purity ratings of 98% or higher.

3. How should lyophilized IGF-1 LR3 1mg be stored prior to reconstitution?

Vials of dry powder should be stored tightly sealed in a dry environment at $-20^\circ C$ protected from light to maintain structural stability.

4. Are Certificates of Analysis (COAs) provided with orders?

Yes. Every order includes or provides access to batch-specific HPLC and Mass Spectrometry reports to verify protein identity and purity for institutional compliance.

5. Can IGF-1 LR3 be used in human clinical applications?

No. All products sold by Suzhou Lanhai Peptide are restricted strictly to laboratory research and development use only and are prohibited from human or clinical application.